{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T01:25:27Z","timestamp":1774747527438,"version":"3.50.1"},"reference-count":23,"publisher":"BMJ","issue":"11","funder":[{"name":"Instituto Salud Carlos III"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2018,5,30]]},"published-print":{"date-parts":[[2018,11]]},"abstract":"<jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>To characterise the clinical and histological features of <jats:italic>MPL<\/jats:italic>-mutated essential thrombocythaemia (ET).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients and methods<\/jats:title>\n                  <jats:p>Bone marrow biopsies of 175 patients with ET were centrally reviewed according to the 2016 WHO classification, including 42 cases with <jats:italic>MPL<\/jats:italic> mutation, 98 <jats:italic>JAK2<\/jats:italic>V617F-mutated and 35 <jats:italic>CALR<\/jats:italic>-mutated. Clinical and histological features were compared among the three genotypes included in the current 2016 WHO classification and among the different types of <jats:italic>MPL<\/jats:italic> mutations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Patients with <jats:italic>MPL<\/jats:italic>-mutated ET were significantly older than those with the other genotypes. Haematological values at diagnosis were similar among <jats:italic>MPL<\/jats:italic>-mutated and <jats:italic>CALR<\/jats:italic>-mutated ET, with both genotypes showing higher platelet counts and lower haemoglobin values than ET with <jats:italic>JAK2<\/jats:italic>V617F genotype. In the bone marrow, the median number of megakaryocytes was higher in <jats:italic>MPL<\/jats:italic> and <jats:italic>CALR<\/jats:italic> than in <jats:italic>JAK2<\/jats:italic>V617F genotype (16, 19 and 14 megakaryocytes per \u00d720 power field, respectively, p=0.004). Histological features of prefibrotic myelofibrosis were rarely observed in <jats:italic>MPL<\/jats:italic> genotype, whereas sinusoidal hyperplasia, dense clusters of megakaryocytes and reticulin fibrosis were more frequent in <jats:italic>CALR<\/jats:italic>-mutated ET, with 11% of such cases fulfilling WHO 2016 histological criteria of prefibrotic myelofibrosis. With a median follow-up of 3.5 years, no significant differences were seen among genotypes regarding survival, vascular complications or myelofibrotic transformation. There were no significant differences in the clinical data or in the histological characteristics depending on the type of <jats:italic>MPL<\/jats:italic> mutation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>\n                     <jats:italic>MPL<\/jats:italic> and <jats:italic>CALR<\/jats:italic> ET genotypes share clinical and histological characteristics. In contrast to <jats:italic>CALR<\/jats:italic> genotype, features of prefibrotic myelofibrosis are uncommon in <jats:italic>MPL<\/jats:italic>-mutated ET.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jclinpath-2018-205227","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T12:20:02Z","timestamp":1529670002000},"page":"975-980","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Essential thrombocythaemia with mutation in <i>MPL<\/i>: clinicopathological correlation and comparison with <i>JAK<\/i>2V617F-mutated and <i>CALR-<\/i>mutated genotypes"],"prefix":"10.1136","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6387-4619","authenticated-orcid":false,"given":"Alberto","family":"Alvarez-Larran","sequence":"first","affiliation":[{"name":"Hematology Department, Hospital Cl\u00ednic-IDIBAPS, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Pathology Department, Hospital Cl\u00ednic-IDIBAPS, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonor","family":"Arenillas","sequence":"additional","affiliation":[{"name":"Pathology Department-IMIM, Hospital del Mar, Universidad Aut\u00f3noma de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariadna","family":"Rubio","sequence":"additional","affiliation":[{"name":"Hematology Department-IMIM, Hospital del Mar, Universitat Aut\u00f3noma de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Arellano-Rodrigo","sequence":"additional","affiliation":[{"name":"Hemotherapy and Hemostasis Department, Hospital Cl\u00ednic-IDIBAPS, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Carlos","family":"Hern\u00e1ndez Boluda","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Cl\u00ednico-INCLIVA, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Papaleo","sequence":"additional","affiliation":[{"name":"Pathology Department-IMIM, Hospital del Mar, Universidad Aut\u00f3noma de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Caballero","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Miguel Servet, Zaragoza, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Sant Pau, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisca","family":"Ferrer-Mar\u00edn","sequence":"additional","affiliation":[{"name":"Hematology and Medical Oncology, Hospital Morales-Messeguer, CIBERER, UCAM, Murcia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Isabel","family":"Mata","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital de la Costa del Sol, Marbella, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"P\u00e9rez-Encinas","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Cl\u00ednico, Santiago de Compostela, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Antonia","family":"Dur\u00e1n","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Son Espases, Palma de Mallorca, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Alonso","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital de Palencia, Palencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Carre\u00f1o-Tarragona","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital 12 de Octubre, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Manuel","family":"Alonso","sequence":"additional","affiliation":[{"name":"Hematology Department, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soledad","family":"Noya","sequence":"additional","affiliation":[{"name":"Hematology Department, Complexo Hospitalario, A Coru\u00f1a, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Magro","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Pr\u00edncipe de Asturias, Alcal\u00e1 de Henares, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"P\u00e9rez","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Virgen de la Arrixaca, Murcia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"L\u00f3pez-Guerra","sequence":"additional","affiliation":[{"name":"Pathology Department, Hospital Cl\u00ednic-IDIBAPS, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Pastor-Gal\u00e1n","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Cl\u00ednico-INCLIVA, Valencia, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Cervantes","sequence":"additional","affiliation":[{"name":"Hematology Department, Hospital Cl\u00ednic-IDIBAPS, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Besses","sequence":"additional","affiliation":[{"name":"Hematology Department-IMIM, Hospital del Mar, Universitat Aut\u00f3noma de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Colomo","sequence":"additional","affiliation":[{"name":"Pathology Department-IMIM, Hospital del Mar, Universidad Aut\u00f3noma de Barcelona, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Rozman","sequence":"additional","affiliation":[{"name":"Pathology Department, Hospital Cl\u00ednic-IDIBAPS, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"2025092505402454000_71.11.975.1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-03-643544"},{"key":"2025092505402454000_71.11.975.2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.118299"},{"key":"2025092505402454000_71.11.975.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312542"},{"key":"2025092505402454000_71.11.975.4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-538983"},{"key":"2025092505402454000_71.11.975.5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-11-539098"},{"key":"2025092505402454000_71.11.975.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-05-579136"},{"key":"2025092505402454000_71.11.975.7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-131664"},{"key":"2025092505402454000_71.11.975.8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-018879"},{"key":"2025092505402454000_71.11.975.9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-01-135897"},{"key":"2025092505402454000_71.11.975.10","doi-asserted-by":"publisher","DOI":"10.1097\/PDM.0b013e3181ecd261"},{"key":"2025092505402454000_71.11.975.11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-661983"},{"key":"2025092505402454000_71.11.975.12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-07-661835"},{"key":"2025092505402454000_71.11.975.13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-486050"},{"key":"2025092505402454000_71.11.975.14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06565.x"},{"key":"2025092505402454000_71.11.975.15","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1038\/bcj.2016.75","article-title":"Molecular characterisation of triple negative essential thrombocythaemia patients by platelet analysis and targeted sequencing","volume":"6","author":"Angona","year":"2016","journal-title":"Blood Cancer J"},{"key":"2025092505402454000_71.11.975.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71142-9"},{"key":"2025092505402454000_71.11.975.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311347"},{"key":"2025092505402454000_71.11.975.18","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.87"},{"key":"2025092505402454000_71.11.975.19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679571"},{"key":"2025092505402454000_71.11.975.20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806356"},{"key":"2025092505402454000_71.11.975.21","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/bjh.14762","article-title":"Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia","volume":"178","author":"Alvarez-Larr\u00e1n","year":"2017","journal-title":"Br J Haematol"},{"key":"2025092505402454000_71.11.975.22","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12990"},{"key":"2025092505402454000_71.11.975.23","doi-asserted-by":"crossref","first-page":"e487","DOI":"10.1038\/bcj.2016.98","article-title":"MPL mutations and palpable splenomegaly are independent risk factors for fibrotic progression in essential thrombocythemia","volume":"6","author":"Haider","year":"2016","journal-title":"Blood Cancer J"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2018-205227","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:40:35Z","timestamp":1758804035000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2018-205227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,10,17]]},"published-print":{"date-parts":[[2018,11]]}},"alternative-id":["10.1136\/jclinpath-2018-205227"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2018-205227","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]}}}